Double protection in patients with a massive thrombus in the infarct-related artery - a single-center retrospective study.

ST-segment elevation myocardial infarction distal protection device manual thrombectomy massive thrombus primary percutaneous coronary intervention

Journal

Postepy w kardiologii interwencyjnej = Advances in interventional cardiology
ISSN: 1734-9338
Titre abrégé: Postepy Kardiol Interwencyjnej
Pays: Poland
ID NLM: 101272671

Informations de publication

Date de publication:
Jun 2023
Historique:
received: 16 10 2022
accepted: 25 02 2023
medline: 19 7 2023
pubmed: 19 7 2023
entrez: 19 7 2023
Statut: ppublish

Résumé

ST-segment elevation myocardial infarction (STEMI) is associated with thrombus formation on a ruptured or ulcerated atherosclerotic plaque. The consequences of a massive thrombus (MT) may include lack of reperfusion, extensive myocardial infarction (MI) and its complications. Although there are various treatment options for patients with coronary thrombi, double protection (DP) - manual thrombectomy (MTH) with a distal protection device (DPD) - has not been tested yet. To present DP outcomes in the treatment of patients with STEMI and MT patients. Fourteen patients with STEMI and MT were included in the study. Those patients underwent primary percutaneous coronary intervention (PPCI) with DP. Inferior MI was found in 12 (85.8%) patients. Stents were implanted in 13 (92.8%) patients. Thrombolysis In Myocardial Infarction (TIMI) Thrombus Grade 5 was present in 11 (78.6%) patients and Grade 4 in 3 (21.4%) patients. The median thrombus length was 39.1 mm. Complete reperfusion (TIMI flow 3) was observed in 11 (78.6%) patients and TIMI flow 2 in 3 (21.4%) patients. Myocardial Blush Grade (MBG) was used in patients with TIMI flow 3 and Grade 3 was found in 5 (35.7%) patients. Resolution in ST-segment elevation > 50% was obtained in 13 (92.8%) patients. No myocardial rupture, stroke, or death occurred during hospitalization. DP in MT patients is a safe and feasible procedure. However, further observations and studies are needed to assess the efficacy of this method.

Identifiants

pubmed: 37465636
doi: 10.5114/aic.2023.129211
pii: 51021
pmc: PMC10351081
doi:

Types de publication

Journal Article

Langues

eng

Pagination

127-134

Informations de copyright

Copyright: © 2023 Termedia Sp. z o. o.

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

N Engl J Med. 2012 Jan 5;366(1):54-63
pubmed: 22216842
J Am Coll Cardiol. 1997 Dec;30(7):1729-34
pubmed: 9385900
Lancet. 2006 Feb 18;367(9510):569-78
pubmed: 16488800
Kardiol Pol. 2011;69(8):763-71
pubmed: 21850615
Am Heart J. 2005 Sep;150(3):557-62
pubmed: 16169340
N Engl J Med. 2008 Feb 7;358(6):557-67
pubmed: 18256391
Med Sci Monit. 2015 Nov 17;21:3540-6
pubmed: 26573108
Neth Heart J. 2010 Nov;18(11):531-6
pubmed: 21113377
Catheter Cardiovasc Interv. 2007 Nov 1;70(5):677-82
pubmed: 17621653
Circ Cardiovasc Interv. 2017 Dec;10(12):
pubmed: 29246912
Am J Cardiol. 2013 Sep 1;112(5):630-5
pubmed: 23711809
Eur Heart J. 2018 Jan 7;39(2):119-177
pubmed: 28886621
Cardiol J. 2009;16(4):332-40
pubmed: 19653176
Int J Cardiol. 2007 Mar 2;116(1):20-6
pubmed: 16891005
N Engl J Med. 2015 Apr 9;372(15):1389-98
pubmed: 25853743
Eur Heart J. 2015 Sep 14;36(35):2364-72
pubmed: 26129947
Eur Heart J. 2012 Oct;33(20):2569-619
pubmed: 22922416
N Engl J Med. 1985 Apr 4;312(14):932-6
pubmed: 4038784
JACC Cardiovasc Interv. 2009 Oct;2(10):934-43
pubmed: 19850252
J Am Coll Cardiol. 2012 Nov 6;60(19):1975-84
pubmed: 23103033
Interv Cardiol. 2019 May 21;14(2):95-101
pubmed: 31178936
JAMA. 2005 Mar 2;293(9):1063-72
pubmed: 15741528
Circulation. 1998 Jun 16;97(23):2302-6
pubmed: 9639373
J Am Coll Cardiol. 2014 May 27;63(20):2088-2098
pubmed: 24583294
J Invasive Cardiol. 2010 Oct;22(10 Suppl B):6B-14B
pubmed: 20947930
J Am Coll Cardiol. 2009 Jul 21;54(4):281-92
pubmed: 19608025
J Am Coll Cardiol. 2007 Oct 9;50(15):1442-9
pubmed: 17919563
N Engl J Med. 2008 May 22;358(21):2205-17
pubmed: 18499565
Kardiol Pol. 2015;73(11):1123
pubmed: 26726728
Am Heart J. 2007 Mar;153(3):343-53
pubmed: 17307410
Am J Cardiol. 2011 Nov 1;108(9):1244-51
pubmed: 22000626
Indian Heart J. 2020 Nov-Dec;72(6):508-516
pubmed: 33357638
JAMA. 1997 Dec 17;278(23):2093-8
pubmed: 9403425
J Am Coll Cardiol. 2010 Oct 12;56(16):1298-306
pubmed: 20691553
Catheter Cardiovasc Interv. 2006 Jun;67(6):887-93
pubmed: 16683272
Circulation. 2003 Aug 5;108(5):548-53
pubmed: 12874191

Auteurs

Piotr Chodór (P)

Silesian Center for Heart Diseases, Department of Cardiology, Congenital Heart Diseases and Electrotherapy, Medical University of Silesia, Zabrze, Poland.

Grzegorz Honisz (G)

Silesian Center for Heart Diseases, Department of Cardiology, Congenital Heart Diseases and Electrotherapy, Medical University of Silesia, Zabrze, Poland.

Krzysztof Wilczek (K)

Silesian Center for Heart Diseases, 3 Department of Cardiology, Medical University of Silesia, Zabrze, Poland.

Marcin Świerad (M)

Silesian Center for Heart Diseases, Department of Cardiology, Congenital Heart Diseases and Electrotherapy, Medical University of Silesia, Zabrze, Poland.

Karolina Chodór-Rozwadowska (K)

Doctoral School, Division of Medical Sciences in Zabrze, Medical University of Silesia, Department of Cardiology, Silesian Center for Heart Diseases, Zabrze, Poland.

Zbigniew Kalarus (Z)

Silesian Center for Heart Diseases, Department of Cardiology, Congenital Heart Diseases and Electrotherapy, Medical University of Silesia, Zabrze, Poland.

Classifications MeSH